alpha by @dming

Meridian Rank

16 stocks · as of 2026-10-27

Q 20M 20G 20V 20E 20

Filters2

Rank	Ticker	Company	MeridianThe Meridian score, from 0 to 100.	QualityHow profitable and financially sound the business is. Graded A (top tenth) to E (bottom tenth).	MomentumHow strongly the share price has been rising. Graded A (top tenth) to E (bottom tenth).	GrowthHow fast the business is growing. Graded A (top tenth) to E (bottom tenth).	ValuationHow cheap the shares are for what the business earns, sells and owns. Graded A (top tenth) to E (bottom tenth).	ExpectationsHow the latest earnings compared with what was expected. Graded A (top tenth) to E (bottom tenth).
Top 10%	NBIXOpen NBIX on Seeking Alpha in a new tab.37% of the way from the 52-week low to the 52-week high.	Neurocrine BiosciencesHealthcare Biotechnology	92	B Quality: 72nd percentile	C Momentum: 66th percentile	B Growth: 86th percentile	C Valuation: 64th percentile	A Expectations: 95th percentile	QualityB Quality: 72nd percentileMomentumC Momentum: 66th percentileGrowthB Growth: 86th percentileValuationC Valuation: 64th percentileExpectationsA Expectations: 95th percentile
Top 20%	EXELOpen EXEL on Seeking Alpha in a new tab.98% of the way from the 52-week low to the 52-week high.	ExelixisHealthcare Biotechnology	89	A Quality: 96th percentile	B Momentum: 88th percentile	D Growth: 25th percentile	C Valuation: 56th percentile	C Expectations: 55th percentile	QualityA Quality: 96th percentileMomentumB Momentum: 88th percentileGrowthD Growth: 25th percentileValuationC Valuation: 56th percentileExpectationsC Expectations: 55th percentile
Top 20%	TECHOpen TECH on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high.	Bio-TechneHealthcare Biotechnology	88	B Quality: 86th percentile	B Momentum: 88th percentile	A Growth: 92nd percentile	D Valuation: 17th percentile	D Expectations: 16th percentile	QualityB Quality: 86th percentileMomentumB Momentum: 88th percentileGrowthA Growth: 92nd percentileValuationD Valuation: 17th percentileExpectationsD Expectations: 16th percentile
Top 20%	ALNYOpen ALNY on Seeking Alpha in a new tab.10% of the way from the 52-week low to the 52-week high.	Alnylam PharmaceuticalsHealthcare Biotechnology	84	A Quality: 96th percentile	D Momentum: 12th percentile	A Growth: 97th percentile	D Valuation: 21st percentile	E Expectations: 3rd percentile	QualityA Quality: 96th percentileMomentumD Momentum: 12th percentileGrowthA Growth: 97th percentileValuationD Valuation: 21st percentileExpectationsE Expectations: 3rd percentile
Top 20%	INCYOpen INCY on Seeking Alpha in a new tab.60% of the way from the 52-week low to the 52-week high.	IncyteHealthcare Biotechnology	81	C Quality: 62nd percentile	B Momentum: 87th percentile	E Growth: 8th percentile	B Valuation: 82nd percentile	A Expectations: 94th percentile	QualityC Quality: 62nd percentileMomentumB Momentum: 87th percentileGrowthE Growth: 8th percentileValuationB Valuation: 82nd percentileExpectationsA Expectations: 94th percentile
Top 30%	HALOOpen HALO on Seeking Alpha in a new tab.100% of the way from the 52-week low to the 52-week high.	Halozyme TherapeuticsHealthcare Biotechnology	78	D Quality: 27th percentile	A Momentum: 96th percentile	C Growth: 49th percentile	D Valuation: 26th percentile	B Expectations: 89th percentile	QualityD Quality: 27th percentileMomentumA Momentum: 96th percentileGrowthC Growth: 49th percentileValuationD Valuation: 26th percentileExpectationsB Expectations: 89th percentile
Top 30%	INSMOpen INSM on Seeking Alpha in a new tab.2% of the way from the 52-week low to the 52-week high.	InsmedHealthcare Biotechnology	73	D Quality: 20th percentile	D Momentum: 18th percentile	A Growth: 98th percentile	E Valuation: 1st percentile	A Expectations: 97th percentile	QualityD Quality: 20th percentileMomentumD Momentum: 18th percentileGrowthA Growth: 98th percentileValuationE Valuation: 1st percentileExpectationsA Expectations: 97th percentile
Top 40%	REGNOpen REGN on Seeking Alpha in a new tab.82% of the way from the 52-week low to the 52-week high.	Regeneron PharmaceuticalsHealthcare Biotechnology	60	C Quality: 38th percentile	C Momentum: 61st percentile	C Growth: 38th percentile	C Valuation: 61st percentile	A Expectations: 93rd percentile	QualityC Quality: 38th percentileMomentumC Momentum: 61st percentileGrowthC Growth: 38th percentileValuationC Valuation: 61st percentileExpectationsA Expectations: 93rd percentile
Bottom 40%	BBIOOpen BBIO on Seeking Alpha in a new tab.36% of the way from the 52-week low to the 52-week high.	BridgeBio PharmaHealthcare Biotechnology	40	No data	D Momentum: 19th percentile	A Growth: 99th percentile	E Valuation: 0th percentile	E Expectations: 2nd percentile	QualityNo dataMomentumD Momentum: 19th percentileGrowthA Growth: 99th percentileValuationE Valuation: 0th percentileExpectationsE Expectations: 2nd percentile
Bottom 40%	UTHROpen UTHR on Seeking Alpha in a new tab.92% of the way from the 52-week low to the 52-week high.	United TherapeuticsHealthcare Biotechnology	33	C Quality: 69th percentile	D Momentum: 13th percentile	D Growth: 18th percentile	C Valuation: 50th percentile	C Expectations: 51st percentile	QualityC Quality: 69th percentileMomentumD Momentum: 13th percentileGrowthD Growth: 18th percentileValuationC Valuation: 50th percentileExpectationsC Expectations: 51st percentile
Bottom 40%	MDGLOpen MDGL on Seeking Alpha in a new tab.20% of the way from the 52-week low to the 52-week high.	Madrigal PharmaceuticalsHealthcare Biotechnology	31	B Quality: 75th percentile	C Momentum: 45th percentile	C Growth: 39th percentile	E Valuation: 5th percentile	B Expectations: 88th percentile	QualityB Quality: 75th percentileMomentumC Momentum: 45th percentileGrowthC Growth: 39th percentileValuationE Valuation: 5th percentileExpectationsB Expectations: 88th percentile
Bottom 20%	RVMDOpen RVMD on Seeking Alpha in a new tab.76% of the way from the 52-week low to the 52-week high.	Revolution MedicinesHealthcare Biotechnology	18	No data	A Momentum: 93rd percentile	D Growth: 14th percentile	E Valuation: 3rd percentile	E Expectations: 2nd percentile	QualityNo dataMomentumA Momentum: 93rd percentileGrowthD Growth: 14th percentileValuationE Valuation: 3rd percentileExpectationsE Expectations: 2nd percentile
Bottom 20%	VRTXOpen VRTX on Seeking Alpha in a new tab.73% of the way from the 52-week low to the 52-week high.	Vertex PharmaceuticalsHealthcare Biotechnology	16	C Quality: 57th percentile	B Momentum: 84th percentile	E Growth: 1st percentile	D Valuation: 24th percentile	D Expectations: 14th percentile	QualityC Quality: 57th percentileMomentumB Momentum: 84th percentileGrowthE Growth: 1st percentileValuationD Valuation: 24th percentileExpectationsD Expectations: 14th percentile
Bottom 20%	SMMTOpen SMMT on Seeking Alpha in a new tab.14% of the way from the 52-week low to the 52-week high.	Summit TherapeuticsHealthcare Biotechnology	16	No data	E Momentum: 2nd percentile	A Growth: 92nd percentile	E Valuation: 1st percentile	D Expectations: 10th percentile	QualityNo dataMomentumE Momentum: 2nd percentileGrowthA Growth: 92nd percentileValuationE Valuation: 1st percentileExpectationsD Expectations: 10th percentile
Bottom 20%	BMRNOpen BMRN on Seeking Alpha in a new tab.30% of the way from the 52-week low to the 52-week high.	BioMarin PharmaceuticalHealthcare Biotechnology	15	D Quality: 13th percentile	B Momentum: 71st percentile	E Growth: 0th percentile	C Valuation: 65th percentile	B Expectations: 89th percentile	QualityD Quality: 13th percentileMomentumB Momentum: 71st percentileGrowthE Growth: 0th percentileValuationC Valuation: 65th percentileExpectationsB Expectations: 89th percentile
Bottom 10%	MRNAOpen MRNA on Seeking Alpha in a new tab.76% of the way from the 52-week low to the 52-week high.	ModernaHealthcare Biotechnology	10	E Quality: 4th percentile	A Momentum: 100th percentile	E Growth: 0th percentile	E Valuation: 2nd percentile	C Expectations: 32nd percentile	QualityE Quality: 4th percentileMomentumA Momentum: 100th percentileGrowthE Growth: 0th percentileValuationE Valuation: 2nd percentileExpectationsC Expectations: 32nd percentile